Effect of moxonidine on blood pressure and sympathetic tone in conscious spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 362, Issue 1, 1998, Pages 61-67

  Nurminen, Marja Leena ^b   Culman, Juraj ^a   Haass, Markus ^c   Chung, Oliver ^a   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood pressure; Clonidine; Heart rate; Moxonidine; Spontaneously hypertensive rat (SHR), conscious; Sympathetic nerve activity

Indexed keywords

ADRENALIN; CLONIDINE; MOXONIDINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MONITORING; BRAIN STEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATECHOLAMINES; CLONIDINE; HEART RATE; HYPERTENSION; IMIDAZOLES; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SPLANCHNIC NERVES; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 0032406994     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00726-2     Document Type: Article

References (25)

1. Amann, K., Greber, D., Gharebaghi, H., Wiest, G., Lange, B., Ganten, U., Mattfeldt, T., Mall, G., 1992. Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats. Am. J. Hypertens. 5, 76-83.
2. Armah, B.I., Hofferber, E., Stenzel, W., 1988. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Arzneim.-Forsch./Drug Res. 38, 1426-1434.
3. Badoer, E., Head, G.A., Korner, P.I., 1983. Effects of intracisternal and intravenous α-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. J. Cardiovasc. Pharmacol. 5, 760-767.
4. 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 273, 1162-1171.
5. Chan, C.K.S., Sannajust, F., Head, G.A., 1996. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J. Pharmacol. Exp. Ther. 276, 411-420.
6. Chan, R.K.W., Chan, Y.S., Wong, T.M., 1991. Electrophysiological properties of neurons in the rostral ventrolateral medulla of normotensive and spontaneously hypertensive rats. Brain Res. 549, 118-126.
7. Da Prada, M., Zürcher, G., 1976. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine with the femtomole range. Life Sci. 19, 1161-1174.
8. Ebihara, H., Kawasaki, H., Nakamura, S., Takasaki, K., Wada, A., 1993. Pressor response to microinjection of clonidine into the hypothalamic paraventricular nucleus in conscious rats. Brain Res. 624, 44-52.
9. 1-imidazoline sites. J. Pharmacol. Exp. Ther. 264, 172-182.
10. Ferrario, C.M., Averill, D.B., 1991. Do primary dysfunctions in neural control of arterial pressure contribute to hypertension?. Hypertension 18, I38-I51, (Suppl. 1).
11. 1-Imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24, S1-S8, (Suppl. 1).
12. Julius, S., Weder, A.B., 1989. Brain and the regulation of blood pressure: a hemodynamic perspective. Clin. Exper.-Theory and Practice A 11, 1-9, Suppl. 1.
13. 2-adrenoceptor-mediated pressor response to clonidine in conscious, spontaneously hypertensive rats. Jpn. J. Pharmacol. 59, 321-331.
14. Kirsch, W., Hutt, H.-J., Plänitz, V., 1990. Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertensive patients. J. Clin. Pharmacol. 30, 1088-1095.
15. Ludbrook, J., 1994. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res. 28, 303-311.
16. Luft, F.C., Veelken, R., Becker, H., Ganten, D., Lang, R.E., Unger, Th., 1985. Effect of uradipil, clonidine, and prazosin on sympathetic tone in conscious rats. Hypertension 8, 303-311.
17. Motz, W., Strauber, B.E., 1994. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation. J. Cardiovasc. Pharmacol. 24, S34-S38, Suppl. 1.
18. 2-adrenoceptors to the cardiovascular effects of intracerebroventricular moxonidine and clonidine in anaesthetized normotensive rats. Pharm. Sci. 2, 593-596.
19. 2-adrenoceptor agonists in anesthetized cats. Br. J. Pharmacol. 98, 1157-1164.
20. 1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine. Arzneim.-Forsch. 47, 1009-1015.
21. 2-adrenoceptors: classification, localization, mechanisms, and targets for drugs. J. Med. Chem. 25, 1389-1401.
22. Unger, Th., Rascher, W., Schuster, Ch., Pavlovitch, R., Schömig, A., Dietz, R., Ganten, D., 1981. Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. Eur. J. Pharmacol. 71, 33-42.
23. Unger, Th., Becker, H., Dietz, R., Ganten, D., Lang, R.E., Rettig, R., Schömig, A., Schwab, N.A., 1984. Antihypertensive effect of the GABA receptor agonist muscimol in spontaneously hypertensive rats. Circ. Res. 54, 30-37.
24. 2-adrenoceptors in the cardiovascular effects of moxonidine. Eur. J. Pharmacol. 282, 19-28.
25. Urban, R., Szabo, B., Starke, K., 1995b. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur. J. Pharmacol. 282, 29-37.